| Summary: | Introduction: Antimicrobial resistance has become one of the biggest threats to global health. Because of the variety of resistance mechanisms that “superbugs” acquire under the wide antibiotic pressure in medicine, they become difficult to treat with commonly used antibiotics. The spread of so-called ''therapeutic problematic microorganisms'' results in extremely limited treatment options of infections, prolonged hospital stay, increased treatment costs and in many cases, the inability to adequately treat and increased mortality. The new strain of bacteria Streptomyces sp. myrophorea was found to be effective at killing both Gram-positive and Gram-negative multidrug resistant pathogens on the World Health Organization’s priority list. The purpose of this review is to provide information about Streptomyces sp. myrophorea. Materials and methods: a review of scientific literature,
studies, and international experience that provide information on Streptomyces sp. myrophorea. Conclusion: The “superbug” problem may be alarming, with news that even our last resort antibiotics are beginning to fail, but there is hope - Streptomyces sp. myrophorea.
|
|---|